Compare Boston Scientific Corporation (BSX) vs Nuwellis Inc (NUWE) Price & Performance

Boston Scientific CorporationTrade

Nuwellis IncTrade

Price performance (Past 24H)

Key statistics

Boston Scientific Corporation vs Nuwellis Inc — how do they compare? Boston Scientific Corporation trades at $51.07 (market cap $74.19B), while Nuwellis Inc trades at $1.49 (market cap $542.80K). The key difference: Boston Scientific Corporation is far larger — about 136680.2× Nuwellis Inc's market cap, and Boston Scientific Corporation is trading nearer its 52-week high, Nuwellis Inc nearer its low. Which is the better fit depends on your goals.

	BSX	NUWE
Market Cap	$74.19B	$542.80K
Sector	Health	Technology
52-Week High	$108.14	$220.50
52-Week Low	$42.63	$1.42
Enterprise Value	$86.27B	-$1.27M

View details →View details →

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

BSX

Boston Scientific posts strong Q2 growth despite U.S. challenges, stock now valued attractively.Seeking Alpha · 1 day agoBullish Boston Scientific to present at Wells Fargo Healthcare Conference and report Q3 2026 results in OctoberPRNewsWire · 2 days agoNeutral View details →

NUWE

View details →

About Boston Scientific Corporation

Boston Scientific produces less invasive medical devices that are inserted into the human body through small openings or cuts. It manufactures products for use in angioplasty, blood clot filtration, cardiac rhythm management, catheter-directed ultrasound imaging, structural heart disease, upper gastrointestinal tract diagnostics, interventional oncology, and treatment of incontinence. The firm markets its devices to healthcare professionals and institutions globally. Foreign sales account for nearly half of the firm's total sales.

About Nuwellis Inc

Nuwellis, Inc. is a medical device company focused on developing and commercializing fluid management solutions. The company's primary product is an ultrafiltration system used in hospitals to remove excess fluid from patients with fluid overload, often associated with conditions such as heart and kidney failure. Nuwellis aims to improve patient outcomes and reduce healthcare costs through its specialized, innovative therapies.